Carmichael Hill & Associates Inc. raised its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 131.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 327 shares of the financial services provider’s stock after buying an additional 186 shares during the period. Carmichael Hill & Associates Inc.’s holdings in MetLife were worth $27,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also modified their holdings of MET. Wolff Wiese Magana LLC raised its holdings in shares of MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares during the period. Fortitude Family Office LLC raised its holdings in shares of MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after buying an additional 266 shares during the period. Bank & Trust Co purchased a new stake in shares of MetLife in the 2nd quarter valued at $39,000. Crewe Advisors LLC raised its holdings in shares of MetLife by 602.5% in the 2nd quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock valued at $39,000 after buying an additional 482 shares during the period. Finally, Larson Financial Group LLC raised its holdings in shares of MetLife by 72.6% in the 2nd quarter. Larson Financial Group LLC now owns 568 shares of the financial services provider’s stock valued at $40,000 after buying an additional 239 shares during the period. 89.81% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several brokerages have weighed in on MET. Barclays cut their price target on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Thursday. Morgan Stanley cut their price target on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a report on Monday, August 19th. Citigroup upped their price target on MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a report on Tuesday, July 23rd. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a report on Friday, October 4th. Finally, Jefferies Financial Group upped their price target on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 27th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, MetLife currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.38.
MetLife Stock Up 0.0 %
Shares of NYSE MET opened at $78.43 on Monday. The stock has a market cap of $54.93 billion, a PE ratio of 15.81, a price-to-earnings-growth ratio of 0.66 and a beta of 1.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.49. MetLife, Inc. has a 52-week low of $58.89 and a 52-week high of $86.94. The business has a 50-day moving average price of $80.59 and a 200 day moving average price of $74.92.
MetLife Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be given a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.78%. MetLife’s dividend payout ratio (DPR) is presently 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- Best Stocks Under $10.00
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Battle of the Retailers: Who Comes Out on Top?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.